Isotechnika Pharma Inc IPHAF

I think it's pretty obvious

[gordches]

The new company is buying to put themselves in position to sell their shares after a four month holding period. The only reason to excercise their option, is the have the option to block a buyout, sell the shares to finance the money they sank into ISA, or to profit from what is goint to happen with ISA within the next few months.
I have been in ISA since 2002. I bought around $1.70, and had the chance to sell at $6.00. At that time, everyone talked of this being a $30 - $50 stock - or more.

I have bought in as low as $.12 to even out my losses - about 50M shares now. I have seen just about everything that could happen with ISA. My advise is waiting for a $3.00 price would make this a 1/2 billion dollar + company - I don't think so.

If it gets anywhere near $1.00 - I will take the money and run - and write off 8 years of 'bad road'

I attribute most of this to terrible management and never getting the proper help to promote ISA. ISA never touted themselves well, nor put out releases to soothe investors or prompt new ones to buy.

I do believe that the technology is sound. I think the applications will slowly leak out to companies that wish to use them. ISA will be mainly living from application to application. All of our partners will profit the most. My guess is management did nothing to help the Roche decision - Roche probably discovered them 'sitting on their hands' and didn't want anything to do with this bunch.

I can see somebody taking us out to acquire a decent income stream for their investors - but that is about all.